La Jolla Pharmaceutical Company EBITDA Margin 2010-2022 | LJPC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for La Jolla Pharmaceutical Company (LJPC) over the last 10 years. The current EBITDA margin for La Jolla Pharmaceutical Company as of June 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-06-30 | $0.05B | $-0.00B | -4.35% |
| 2022-03-31 | $0.05B | $0.00B | 5.88% |
| 2021-12-31 | $0.08B | $0.02B | 30.67% |
| 2021-09-30 | $0.07B | $0.02B | 27.03% |
| 2021-06-30 | $0.07B | $0.01B | 14.29% |
| 2021-03-31 | $0.06B | $-0.00B | -8.33% |
| 2020-12-31 | $0.03B | $-0.03B | -94.12% |
| 2020-09-30 | $0.03B | $-0.05B | -176.67% |
| 2020-06-30 | $0.03B | $-0.07B | -255.56% |
| 2020-03-31 | $0.03B | $-0.09B | -314.81% |
| 2019-12-31 | $0.02B | $-0.11B | -456.52% |
| 2019-09-30 | $0.02B | $-0.12B | -615.00% |
| 2019-06-30 | $0.02B | $-0.15B | -852.94% |
| 2019-03-31 | $0.01B | $-0.17B | -1292.31% |
| 2018-12-31 | $0.01B | $-0.19B | -1890.00% |
| 2016-12-31 | $0.00B | $-0.08B | inf% |
| 2016-09-30 | $0.00B | $-0.06B | inf% |
| 2016-06-30 | $0.00B | $-0.05B | -5300.00% |
